Mark Batshaw, MD Executive Vice President, Physician-in-Chief & Chief Academic Officer



Mark Batshaw, MD, is Executive Vice President, Physician-in-Chief & Chief Academic Officer of Children's National Health System, where he also serves as director of the Children's Research Institute. He is chairman of Pediatrics and Associate Dean for Academic Affairs at the George Washington University School of Medicine and Health Sciences.  

Dr. Batshaw completed his undergraduate degree at the University of Pennsylvania and attended medical school at the University of Chicago. He completed his residency in pediatrics at the Hospital for Sick Children/University of Toronto in Toronto, Ontario, and his post-doctoral fellowship in neurodevelopmental pediatrics at the Kennedy Institute of Johns Hopkins University School of Medicine.Dr. Batshaw has spent his entire career in the care of children with developmental disabilities. His research focus is inborn errors of urea synthesis, in which he is considered an international authority in development and testing of innovative therapies. He has published more than 200 articles and reviews and is the senior editor of the classic textbook Children with Disabilities, now in its seventh edition.Dr. Batshaw lives in Washington, DC, with his wife, Karen, an international adoption social worker. They have three adult children.

Education & Training

Education & Training

  • Fellowship Program, Developmental Pediatrics, 1975
    Johns Hopkins University School of Medicine
  • Residency Program, Pediatrics, 1973
    University of Toronto
  • MD, 1971
    University of Chicago
  • BA, Natural Science, 1967
    University of Pennsylvania


Urea Cycle Disorders Consortium Foresees Innovation from Major NIH Funding

Children’s National Health System’s  Urea Cycle Disorders Consortium was awarded $6.25 million over the next five years in the latest round of funding  from the National Institutes of Health (NIH) to perform clinical research and develop new treatments for patients with urea cycle disorders (UCD), rare but devastating genetic conditions.

Research & Publications

Research & Publications

A Pilot Study of In Vivo Liver Directed Gene Transfer With an Adenoriral Vector in Subjects with Partial Ornithine Transcarbamylase Deficiency

(2002) Gene Therapy

Brain Development and the Ontogeny of Developmental Disabilities

(2002) Advanced Pediatrics

Correction of Argininosuccinate Synthetase AS Deficiency in a Murine Model of Citrullinemia With Recombinant Adenovirus Carrying Human AS cDNA

(2000) Gene Therapy

Differences in the Human and Mouse Amino Terminal Leader Peptides of Ornithine Transcarbamylase Affect Mitochondrial Import and Efficacy of Adenoviral Vectors

(2001) Human Gene Therapy

Fatal Systemic Inflammatory Response Syndrome in a Orthinine Transcarbamylase Deficient Patient Following Adenoviral Gene Transfer

(2003) Molecular Genetics and Metabolism

LongTerm Gene Transfer to Mouse Fetuses With Recombinant Adenoviral and AdenoAssociated Virus AAV Vectors

(2000) Gene Therapy

Metabolic and Neuropsychological Phenotype in Women Heterozygous for Ornithine Transcarbamylase Deficiency

(2004) Annals of Neurology

Prospects for Prenatal Gene Therapy in Disorders Causing Mental Retardation

(2001) Mental Retardation and Developmental Disabilities Research Reviews

The Origins of Autism

(2001) Pediatric Research

Transient Depletion of CD4 Lymphocyte Improved Efficacy of Repeated Administration of Recombinant Adenovirus in the Ornithine Transcarbamylase Deficiency Sparse Fur Mice

(2000) Gene Therapy

View publications on PubMed

Children's National in Your Neighborhood

A location marker

Did you know Children’s National has more than 50 locations throughout the region? Find one that’s convenient for your family.

Find a Children's Location Near You